Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
- Published In:
- Diabetes care, 39(7), 1241-9 (2016)
- Authors:
- Kazda, Christof M, Ding, Ying, Kelly, Ronan P, Garhyan, Parag, Shi, Chunxue, Lim, Chay Ngee, Fu, Haoda, Watson, David E, Lewin, Andrew J, Landschulz, William H, Deeg, Mark A, Moller, David E, Hardy, Thomas A
- Database ID:
- RPEP-02985
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02985APA
Kazda, Christof M; Ding, Ying; Kelly, Ronan P; Garhyan, Parag; Shi, Chunxue; Lim, Chay Ngee; Fu, Haoda; Watson, David E; Lewin, Andrew J; Landschulz, William H; Deeg, Mark A; Moller, David E; Hardy, Thomas A. (2016). Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.. Diabetes care, 39(7), 1241-9. https://doi.org/10.2337/dc15-1643
MLA
Kazda, Christof M, et al. "Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.." Diabetes care, 2016. https://doi.org/10.2337/dc15-1643
RethinkPeptides
RethinkPeptides Research Database. "Evaluation of Efficacy and Safety of the Glucagon Receptor A..." RPEP-02985. Retrieved from https://rethinkpeptides.com/research/kazda-2016-evaluation-of-efficacy-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.